tiprankstipranks
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market

Lyra Therapeutics (LYRA) Income Statement

Compare
289 Followers

Lyra Therapeutics Income Statement

Last quarter (Q3 2024), Lyra Therapeutics's total revenue was $195.00K, a decrease of -64.15% from the same quarter last year. In Q3, Lyra Therapeutics's net income was $-11.87M. See Lyra Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.56M$ 1.36M$ 285.00K$ 0.00$ 0.00
Gross Profit
$ 1.56M$ 296.00K$ -716.00K$ -95.00K$ -27.00K
Operating Expenses
$ 68.68M$ 56.35M$ 43.90M$ 22.21M$ 16.52M
Depreciation and Amortization
$ 278.00K$ 1.07M$ 1.00M$ 95.00K$ 27.00K
EBITDA
$ -65.25M$ -53.92M$ -42.61M$ -22.11M$ -16.49M
Operating Income
$ -67.12M$ -56.31M$ -43.62M$ -22.21M$ -16.52M
Other Income/Expenses
$ 4.50M$ 1.04M$ 102.00K$ 82.00K$ 213.00K
Pretax Income
$ -62.62M$ -55.27M$ -43.51M$ -22.13M$ -16.31M
Net Income
$ -62.68M$ -55.28M$ -42.41M$ -22.05M$ -16.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.26$ -1.83$ -3.27$ -2.57$ -1.25
Diluted EPS
$ -1.26$ -1.83$ -3.27$ -2.57$ -1.25
Weighted Average Shares Outstanding
49.80M 30.24M 12.99M 8.59M 12.92M
Weighted Average Shares Outstanding (Diluted)
49.80M 30.24M 12.99M 8.59M 12.92M
Currency in USD

Lyra Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis